VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is testing VV-14299 and VV-14300 or VV-14300 alone in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system. VV-14299 and VV-14300 are investigational gene therapies that are injected into muscle and are designed to work together to help remove excess sugar from the blood.
Epistemonikos ID: befbc437ca213ec73c6e71a4f9c2e258b96b3bdf
First added on: Sep 22, 2026